IMpower150 update from ELCC: atezolizumab and bevacizumab improve survival
The IMpower150 trial (NCT02366143) was the first to explore chemotherapy, immunotherapy with atezolizumab and anti-angiogenic therapy with bevacizumab for non-small cell lung cancer (NSCLC). In this i...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Transforming outcomes in advanced lung cancer: immunotherapy in unselected patients
Immunotherapeutic agents are increasingly becoming incorporated into clinical practice; however, there is still much to learn, including their optimal combinations, sequencing and usage. In this inter...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Pembrolizumab monotherapy for NSCLC: KEYNOTE-024 update
The Phase III KEYNOTE-024 trial (NCT02142738) compared pembrolizumab monotherapy with standard platinum-based chemotherapy for previously untreated metastatic non-small cell lung cancer (NSCLC) with h...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Pembrolizumab and epacadostat for NSCLC: ECHO-306/KEYNOTE-715
The European Lung Cancer Congress (ELCC) 2018, in Geneva, Switzerland, presented an array of exciting lung cancer trial updates. Speaking from the meeting, Marina Garassino, MD, of the Istituto Nazion...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Which NSCLC patients should receive chemotherapy and anti-angiogenics?
Anti-angiogenic therapy has proven to be useful tool for the treatment of non-small cell lung cancer (NSCLC) in the frontline setting. Excitingly, there are now anti-angiogenic agents that can be used...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Treating NSCLC with CNS involvement: TKIs with high penetrance
The treatment of brain metastases in non-small cell lung cancer (NSCLC) is a challenge, as the majority of the drugs used to treat NSCLC exhibit low penetrance to the brain. Here, Marina Garassino, MD...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
There will be drugs: lessons from lung cancers therapeutic oil boom
With the recent revolution of drugs for the treatment of lung cancer, particularly non-small cell lung cancer (NSCLC), what lessons can be learned? Here, speaking at the 2018 Hematology/Oncology Pharm...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Acquired resistance: facing the challenge of immunotherapy in patients with lung cancer
Could being proactive, by treating lung cancer patients with next-generation drugs, help reduce the risk of acquired resistance? In this interesting interview, Ross Camidge, MD, PhD, of University of ...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
More focus is needed on subtypes of lung cancer that do not have FDA-approved targeted therapies
There are now four FDA approvals that have molecular-specific licenses for lung cancer, these include ALK rearrangements, EGFR mutations, BRAF V600E mutations and ROS1 rearrangements. Now, speaking at...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Immunotherapy options for NSCLC: nivolumab, pembrolizumab or atezolizumab?
How do you decide on which drug to use when treating non-small cell lung cancer (NSCLC) patients in a second-line setting? Here, speaking at the Hematology/Oncology Pharmacy Association (HOPA) Annual ...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Progression is progression! The importance of monitoring the efficacy of immunotherapy in NSCLC
Recently, due to the revolution of immunotherapy in the treatment of nonsmall cell lung cancer (NSCLC), more drugs are being licensed to treat patients in the second-line setting. Although overall su...
Author: VJOncology
Added: 04/20/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 20, 2018 Category: Cancer & Oncology Source Type: podcasts
Join GRACE for Advances in Immunotherapy Patient Forum [720p]
Advances in immunotherapy - what lung cancer patients need to know.
Author: cancergrace
Added: 04/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Should Immunotherapy Stop in Responding Patients After a Fixed Duration of Treatment_ [720p]
Dr. Jack West shares updates to our Lung Cancer Video Library for 2017 -- Should Immunotherapy Stop in Responding Patients After a Fixed Duration of Treatment? <a target='_blank' href='http://cancerGRACE.org/'>http://cancerGRACE.org/...</a>
Author: cancergrace
Added: 04/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2018 Category: Cancer & Oncology Source Type: podcasts
What Is the Optimal Follow-up for Patients After Resection of an Early Stage NSCLC_ [720p]
Dr. Jack West offers 2017 updates to the GRACE Lung Cancer Video Library discussion on the optimal follow-up for patients after resection of an early stage non-small cell lung cancer (NSCLC). IFCT0302...
Author: cancergrace
Added: 04/17/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 17, 2018 Category: Cancer & Oncology Source Type: podcasts
Pennell Liquid Biopsies for EGFR T790M NonSmall Cell Lung Cancer NSCLC [720p]
Dr. Nate Pennell, Director of Lung Cancer Medical Oncology at Cleveland Clinic Taussig Cancer Center shares 2017 updates for our Lung Cancer Video Library. In this update, Dr. Pennell discusses Liquid...
Author: cancergrace
Added: 04/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 16, 2018 Category: Cancer & Oncology Source Type: podcasts
